印度视网膜母细胞瘤:1457例患者(2074只眼)的临床表现与结局
该回顾性研究分析了印度1457例视网膜母细胞瘤患者(2074只眼)的临床表现、治疗与结局。患者就诊平均年龄29个月,最常见表现为白瞳症(75%)和眼球突出(6%),91%肿瘤位于眼内。中位随访30个月时92%患者存活,Kaplan-Meier分析1年、3年、5年和10年生存率分别为94%、91%、90%和89%。
要点
- 亚洲印度人群视网膜母细胞瘤最常见就诊体征为白瞳症(75%)和眼球突出(6%)。
- 91%肿瘤位于眼内,9%就诊时已有眼外 extension。
- 中位随访30个月时92%患者存活,10年生存率89%。
核心结论
- 亚洲印度人群视网膜母细胞瘤最常见就诊体征为白瞳症和眼球突出,经适当治疗生存率良好,为92%。
研究设计与样本
- 回顾性研究,纳入1457例视网膜母细胞瘤患者(2074只眼)。
主要发现
- 就诊平均年龄29个月(中位24个月,范围<1-370个月),男性812例(56%),女性645例(44%)。
- 单侧57%(834例),双侧43%(623例),家族性4%(55例)。
- 最常见主诉为白瞳症(1100例,75%)、眼球突出(91例,6%)、斜视(77例,5%)和红眼(68例,5%)。
- 91%(1889只眼)肿瘤位于眼内,9%(185只眼)就诊时已有眼外 extension。
- 最常见初始治疗方式为全身化疗(1171例,60%)和眼球摘除(674例,35%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To study the clinical presentation, treatment, and outcome of patients with retinoblastoma (RB) in India. METHODS: Retrospective study of 1,457 patients with RB (2,074 eyes). RESULTS: The mean age at presentation of RB was 29 months (median, 24 months; range, <1-370 months). There were 812 (56%) men and 645 (44%) women with unilateral presentation of RB in 57% (n = 834) and bilateral in 43% (n = 623). Familial RB was present in 4% (n = 55). The most common presenting complaints included leukocoria (n = 1,100; 75%), proptosis (n = 91; 6%), strabismus (n = 77; 5%), and red eye (n = 68; 5%). Most (n = 1,889; 91%) tumors were intraocular in location, and 185 (n = 185; 9%) had extraocular tumor extension at presentation. The most common modalities of primary treatment-included systemic chemotherapy (n = 1,171; 60%) and enucleation (n = 674; 35%). At a mean follow-up period of 44 months (median, 30 months; range, 3-234 months), 92% (n = 1,206) were alive, and 108 (8%) patients died because of RB. Based on Kaplan-Meier analysis, the survival at 1, 3, 5, and 10 years was 94%, 91%, 90%, and 89%, respectively. CONCLUSION: The most common presenting signs of RB in Asian Indian population are leukocoria and proptosis. With appropriate treatment, the survival rate is favorable at 92%.
引用
- Kaliki S, Patel A, Iram S, et al. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes). Retina. 2019. PMID: 29210937. doi:10.1097/IAE.0000000000001962
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。